One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood.v126.23.1328.1328
Copy DOI Journal: Blood |  Publication Date: Dec 3, 2015 |
 Citations: 49 |
Affiliation: Massachusetts General Hospital, University of Alabama at Birmingham, Dana-Farber Cancer Institute, Cincinnati Children's Hospital Medical Center, Memorial Sloan Kettering Cancer Center, Moffitt Cancer Center, Johns Hopkins University, Mayo Clinic, Boston Children's Hospital, University of Alabama, Children's Healthcare of Atlanta, Robert Cizik Eye Clinic, Seagen (United States), City Of Hope National Medical CenterA Phase 1 Study of Denintuzumab Mafodotin (SGN-CD19A) in Adults with Relapsed or Refractory B-Lineage Acute Leukemia (B-ALL) and Highly Aggressive Lymphoma
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
